Table 2.
Statistically significant correlations between renal function indicators and other variables
| Correlation | Spearmann's coefficient | P value |
|---|---|---|
| UREA‐Furosemide (mg/kg/day) | 0.31 | <.001 |
| UREA‐IRIS | 0.55 | <.001 |
| UREA‐sCr | 0.57 | <.001 |
| UREA Treatment versus NO‐Treatment | 0.18 | .02 |
| UREA‐ACVIM | 0.19 | .02 |
| UREA‐SBP | 0.59 | .06 |
| UREA‐WBC | 0.15 | .07 |
| sCr‐ACVIM | 0.29 | <.001 |
| sCr Treatment versus NO‐Treatment | 0.31 | <.001 |
| sCr‐Murmur Grade | 0.23 | .01 |
| sCr‐WBC | 0.18 | .04 |
| sCr‐SBP | 0.52 | .10 |
| sCr‐Hb | −0.11 | .21 |
| sCr‐MCHC | −0.08 | .36 |
| ACVIM‐BW | −0.23 | <.001 |
| ACVIM‐Furosemide (mg/kg/day) | 0.28 | <.001 |
| ACVIM‐ESVI | 0.37 | <.001 |
| ACVIM‐E/A | 0.42 | <.001 |
| ACVIM‐Murmur Grade | 0.46 | <.001 |
| ACVIM‐EDVI | 0.56 | <.001 |
| ACVIM‐ LVEDDn | 0.57 | <.001 |
| ACVIM‐Evmax | 0.62 | <.001 |
| ACVIM‐LA/Ao | 0.66 | <.001 |
| ACVIM Treatment versus NO‐Treatment | 0.95 | <.001 |
| ACVIM‐MR | −0.25 | .01 |
| ACVIM‐HR | 0.37 | .01 |
| ACVIM‐TR | 0.27 | .02 |
| IRIS Treatment versus NO‐Treatment | 0.26 | <.001 |
| IRIS‐LA/Ao | 0.23 | .01 |
| IRIS‐LVEDDn | 0.21 | .01 |
| IRIS‐HR | 0.32 | .02 |
| IRIS‐WBC | 0.15 | .07 |
| IRIS‐Hb | −0.09 | .27 |
Serum urea (UREA), serum creatinine (sCr), body weight (BW), heart rate (HR), systolic blood pressure (SBP), white blood cells (WBC), hemoglobin (Hb), mean corpuscular hemoglobin concentration (MCHC), End systolic volume index (ESVI), End diastolic volume index (EDVI), normalized left ventricular end diastolic diameter (LVEDDn), left atrial to aortic root ratio (LA/Ao), mitral valve inflow (E peak velocity—EVmax, E/A ratio), peak velocity of mitral and tricuspid regurgitations (MR and TR).